<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="30">
  <!-- This xml conforms to:  http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>Information obtained from ClinicalTrials.gov on October 20, 2011</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01255449</url>
  </required_header>
  <id_info>
    <org_study_id>FOT-BOS-01</org_study_id>
    <nct_id>NCT01255449</nct_id>
  </id_info>
  <brief_title>Respiratory Impedance and Obliterative Bronchiolitis</brief_title>
  <acronym>FOT-BOS</acronym>
  <official_title>Predictive Value of Within-breath Respiratory Input Impedance in the Early Diagnosis of Obliterative Bronchiolitis After Allogeneic Hematopoietic Stem Cell Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy</source>
  <oversight_info>
    <authority>Italy: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study will be to test the hypothesis that changes in within-breath
      total respiratory input impedance (Zrs) may provide an early evidence of obliterative
      bronchiolitis after allogeneic hematopoietic stem cell transplantation (HSCT). Before and
      after HSCT, Zrs will be measured by a modified forced oscillation technique (FOT) during
      spontaneous breathing both at baseline and 30 min after albuterol inhalation . Such
      technique may be particularly sensitive to small changes in lung mechanics observed in the
      early stages of peripheral airflow obstruction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1.0 INTRODUCTION

        -  Shortly after the introduction of allogeneic HSCT in clinical practice, it was
           recognized that standard pulmonary function tests (PFTs) are sensitive enough to detect
           HSCT-related respiratory complications [PMID: 2661259; PIMD: 8823260]. Accordingly, the
           finding of a progressive obstructive abnormality of new onset was considered as the
           functional hallmark of obliterative bronchiolitis (OB) [PMID: 16338616; PMID:
           19896545]. As a result, routinely performed spirometry has been proposed as a
           non-invasive tool to monitor the risk of OB in HSCT population [PMID: 17470622]. Yet,
           due to a peripheral airway involvement in OB, the sensitivity of conventional PFTs for
           early detection of OB is low [PMID: 2298060]. For instance, it does not exceed 75% in
           lung-transplanted population as the decrease of forced expiratory volume in 1 s (FEV1)
           may occur at a stage when the process is already irreversible and  potentially
           life-threatening [PMID: 9246138].

      2.0 EXPERIMENTAL HYPOTHESIS

        -  Because the branching pattern of the bronchial tree results in an increasingly large
           number of small airways with a luminal diameter of less than 2 mm in peripheral
           generations, these airways contribute little to total pulmonary resistance [PMID:
           5442364; PMID: 651978]. Intuitively, a large proportion of small airways may be damaged
           or obliterated without impairing any of the conventional PFTs. In this regard, a
           previous study [PMID: 12186817] pointed out that indexes of ventilation distribution
           may provide an early evidence of OB after lung transplantation. In particular, some
           authors [PMID: 12186817] have found that tests of ventilation distribution invariably
           deteriorated about 1 yr before a 20% decrease in FEV1 was apparent. Previous studies
           [PMID: 970731; PMID: 507525] showed that total respiratory input impedance (Zrs),
           measured by a forced oscillation technique (FOT) during spontaneous breathing, may be
           particularly sensitive to small changes in lung mechanics observed in the early stages
           of smoking-related airflow obstruction. Subsequently, it was developed a modified FOT
           to identify within-breath differences in Zrs, with values of Zrs representing the sum
           of respiratory system resistance (Rrs) and reactance (Xrs), the latter being the
           imaginary part of the former [PMID: 14979497; PMID: 19164347]. This method allows the
           assessment of more breaths and adds a potential quantitative evaluation of
           instantaneous inspiratory and expiratory Rrs and Xrs before and after external
           interventions such as a deep inspiration, bronchodilator drugs, etc. Although these
           effects can be identified when within-breath analysis is performed [PMID: 14979497],
           most published reports of oscillatory mechanics on chronic obstructive pulmonary
           disease (COPD) only report total respiratory cycle data [PMID: 1519830; PMID:
           10489847].

      3.0 STUDY RATIONALE

        -  The aim of the present study will be to test the hypotheses that:

             1. post-HSCT changes in within-breath Rrs and Xrs may provide an earlier evidence of
                OB than standard PFTs. Indeed, the obliteration of terminal bronchioles, observed
                in up to 48% of OB patients following HSCT [PMID: 17470622], could make the real
                part of Zrs abnormally high [PMID: 5653219] and ventilation more heterogeneous;

             2. post-HSCT changes of airway responsiveness to acute bronchoactive interventions
                such as a deep inspiration to total lung capacity and/or a bronchodilator drug
                (i.e., albuterol) may be detected by our modified FOT. We speculate that these
                changes may represent an early sign of OB. Although a previous study from our
                group failed to find an increase in airway responsiveness after HSCT without
                pulmonary complications [PMID: 18684842], we have recently shown that airway
                smooth muscle tone may play an active role in the airflow obstruction of OB [PMID:
                20724742].

      4.0 STUDY DESIGN

        -  Before and at regular intervals (2-4 wk onward) after HSCT, patients will attend our
           laboratory and perform all PFTs measurements in the same order. Firstly, the patient
           will breathe spontaneously through the modified FOT system for 5 min and then, without
           disconnecting from the apparatus, perform an inspiratory capacity maneuver and soon
           after resume spontaneous breathing for the next 2 min. Subsequently, spirometry,
           transmural total body plethysmography and CO diffusing capacity of the lung (standard
           PFTs) will be taken in triplicate. Thirty minutes after inhaling four separate doses of
           100 μg of albuterol, the modified FOT measurements and standard PFTs will be repeated
           anew.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification:  Efficacy Study, Intervention Model:  Single Group Assignment, Masking:  Open Label, Primary Purpose:  Diagnostic</study_design>
  <primary_outcome>
    <measure>Changes in within-breath total respiratory input impedance following hematopoietic stem cell transplantation (HSCT)</measure>
    <time_frame>Before and at 2-wk intervals onward after HSCT</time_frame>
    <safety_issue>No</safety_issue>
    <description>Changes in within-breath total respiratory input impedance (Zrs), resistance (Rrs) and reactance (Xrs) after HSCT. Zrs, Rrs and Xrs will be measured at baseline and 30 min after albuterol inhalation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in standard pulmonary function tests following hematopoietic stem cell transplantation (HSCT)</measure>
    <time_frame>Before and at 2-wk intervals onward after HSCT</time_frame>
    <safety_issue>No</safety_issue>
    <description>Changes in standard pulmonary function tests will be measured at baseline and 30 min after albuterol inhalation</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Hematopoietic Stem Cell Transplantation</condition>
  <condition>Obliterative Bronchiolitis</condition>
  <arm_group>
    <arm_group_label>albuterol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>albuterol</intervention_name>
    <description>400 mcg by inhalation</description>
    <arm_group_label>albuterol</arm_group_label>
    <other_name>Broncovaleas pressurized solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  consecutive, clinically-stable, outpatients undergoing allogeneic HSCT (sourcing from
             bone marrow) for hematological malignancies

          -  values of standard PFTs within normal range before HSCT

          -  good collaboration during the maneuvers

        Exclusion Criteria:

          -  patients showing any spirometric and/or volumetric abnormality before HSCT

          -  poor collaboration and/or coordination during the maneuvers

          -  any clinically-significant respiratory disease (bronchial asthma, COPD, cystic
             fibrosis, etc.) before HSCT
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giovanni Barisione, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliera Universitaria San Martino, Genova, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>U.O. Medicina Preventiva e del Lavoro, Laboratorio di Fisiopatologia Respiratoria, Azienda Ospedaliera Universitaria San Martino</name>
      <address>
        <city>Genova</city>
        <zip>16132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Barisione, MD</last_name>
      <phone>+39 010 5553367</phone>
      <email>giovanni.barisione@hsanmartino.it</email>
    </contact>
    <investigator>
      <last_name>Giovanni Barisione, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vito Brusasco, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Bacigalupo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raffaele Dellacà, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pasquale Pio Pompilio, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emanuele Crimi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Riccardo Pellegrino, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francesco Copello, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Rodríguez-Roisin R, Roca J, Grañena A, Agustí AG, Marín P, Rozman C. Lung function in allogeneic bone marrow transplantation recipients. Eur Respir J. 1989 Apr;2(4):359-65.</citation>
    <PMID>2661259</PMID>
  </reference>
  <reference>
    <citation>Gore EM, Lawton CA, Ash RC, Lipchik RJ. Pulmonary function changes in long-term survivors of bone marrow transplantation. Int J Radiat Oncol Biol Phys. 1996 Aug 1;36(1):67-75.</citation>
    <PMID>8823260</PMID>
  </reference>
  <reference>
    <citation>Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogelsang G, Flowers ME. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005 Dec;11(12):945-56.</citation>
    <PMID>16338616</PMID>
  </reference>
  <reference>
    <citation>Chien JW, Duncan S, Williams KM, Pavletic SZ. Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2010 Jan;16(1 Suppl):S106-14. Epub 2009 Nov 5. Review.</citation>
    <PMID>19896545</PMID>
  </reference>
  <reference>
    <citation>Soubani AO, Uberti JP. Bronchiolitis obliterans following haematopoietic stem cell transplantation. Eur Respir J. 2007 May;29(5):1007-19. Review.</citation>
    <PMID>17470622</PMID>
  </reference>
  <reference>
    <citation>Otulana BA, Higenbottam T, Ferrari L, Scott J, Igboaka G, Wallwork J. The use of home spirometry in detecting acute lung rejection and infection following heart-lung transplantation. Chest. 1990 Feb;97(2):353-7.</citation>
    <PMID>2298060</PMID>
  </reference>
  <reference>
    <citation>Van Muylem A, Mélot C, Antoine M, Knoop C, Estenne M. Role of pulmonary function in the detection of allograft dysfunction after heart-lung transplantation. Thorax. 1997 Jul;52(7):643-7.</citation>
    <PMID>9246138</PMID>
  </reference>
  <reference>
    <citation>Mead J. The lung's &quot;quiet zone&quot;. N Engl J Med. 1970 Jun 4;282(23):1318-9. No abstract available.</citation>
    <PMID>5442364</PMID>
  </reference>
  <reference>
    <citation>Cosio M, Ghezzo H, Hogg JC, Corbin R, Loveland M, Dosman J, Macklem PT. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med. 1978 Jun 8;298(23):1277-81.</citation>
    <PMID>651978</PMID>
  </reference>
  <reference>
    <citation>Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med. 2002 Aug 15;166(4):440-4. Review. No abstract available.</citation>
    <PMID>12186817</PMID>
  </reference>
  <reference>
    <citation>Kjeldgaard JM, Hyde RW, Speers DM, Reichert WW. Frequency dependence of total respiratory resistance in early airway disease. Am Rev Respir Dis. 1976 Sep;114(3):501-8.</citation>
    <PMID>970731</PMID>
  </reference>
  <reference>
    <citation>Hayes DA, Pimmel RL, Fullton JM, Bromberg PA. Detection of respiratory mechanical dysfunction by forced random noise impedance parameters. Am Rev Respir Dis. 1979 Nov;120(5):1095-100.</citation>
    <PMID>507525</PMID>
  </reference>
  <reference>
    <citation>Dellacà RL, Santus P, Aliverti A, Stevenson N, Centanni S, Macklem PT, Pedotti A, Calverley PM. Detection of expiratory flow limitation in COPD using the forced oscillation technique. Eur Respir J. 2004 Feb;23(2):232-40.</citation>
    <PMID>14979497</PMID>
  </reference>
  <reference>
    <citation>Dellacà RL, Pompilio PP, Walker PP, Duffy N, Pedotti A, Calverley PM. Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD. Eur Respir J. 2009 Jun;33(6):1329-37. Epub 2009 Jan 22.</citation>
    <PMID>19164347</PMID>
  </reference>
  <reference>
    <citation>Chalker RB, Celli BR, Habib RH, Jackson AC. Respiratory input impedance from 4 to 256 Hz in normals and chronic airflow obstruction: comparisons and correlations with spirometry. Am Rev Respir Dis. 1992 Sep;146(3):570-6.</citation>
    <PMID>1519830</PMID>
  </reference>
  <reference>
    <citation>Farré R, Peslin R, Rotger M, Barberá JA, Navajas D. Forced oscillation total respiratory resistance and spontaneous breathing lung resistance in COPD patients. Eur Respir J. 1999 Jul;14(1):172-8.</citation>
    <PMID>10489847</PMID>
  </reference>
  <reference>
    <citation>Grimby G, Takishima T, Graham W, Macklem P, Mead J. Frequency dependence of flow resistance in patients with obstructive lung disease. J Clin Invest. 1968 Jun;47(6):1455-65.</citation>
    <PMID>5653219</PMID>
  </reference>
  <reference>
    <citation>Barisione G, Bacigalupo A, Crimi E, Van Lint MT, Lamparelli T, Brusasco V. Changes in lung volumes and airway responsiveness following haematopoietic stem cell transplantation. Eur Respir J. 2008 Dec;32(6):1576-82. Epub 2008 Aug 6.</citation>
    <PMID>18684842</PMID>
  </reference>
  <reference>
    <citation>Barisione G, Bacigalupo A, Crimi E, Brusasco V. Acute bronchodilator responsiveness in bronchiolitis obliterans syndrome following hematopoietic stem cell transplantation. Chest. 2010 Aug 19; [Epub ahead of print]</citation>
    <PMID>20724742</PMID>
  </reference>
  <verification_date>December 2010</verification_date>
  <lastchanged_date>December 10, 2010</lastchanged_date>
  <firstreceived_date>December 6, 2010</firstreceived_date>
  <responsible_party>
    <name_title>Giovanni Barisione, MD</name_title>
    <organization>Azienda Ospedaliera Universitaria San Martino</organization>
  </responsible_party>
  <keyword>Forced oscillation technique</keyword>
  <keyword>Respiratory input impedance</keyword>
  <keyword>Allogeneic hematopoietic stem cell transplantation</keyword>
  <keyword>Obliterative bronchiolitis</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiolitis</mesh_term>
    <mesh_term>Bronchiolitis Obliterans</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Albuterol</mesh_term>
  </intervention_browse>
</clinical_study>
